Cetya Therapeutics winner of bioscience venture showcase
FORT COLLINS — The Colorado Bioscience Association named Cetya Therapeutics Inc. the winner of its venture showcase at the Colorado Life Science Innovation Forum.
The Fort Collins-based company focuses on developing targeted cancer treatments through the commercialization of largazole analogs by inhibiting histone deacetylases (HDACs). HDACs are used in psychiatry and neurology as mood stabilizers and anti-epileptics; Cetya is using them for targeted cancer treatments and are using the enzyme largazole to do that.
Jennifer Jones, vice president of the Colorado Bioscience Association, presented Cetya CEO Cliff Hendrick with a $7,500 award. The award…
THIS ARTICLE IS FOR SUBSCRIBERS ONLY
Continue reading for less than $3 per week!
Get a month of award-winning local business news, trends and insights
Access award-winning content today!
Related Posts
-
Voters were giving the extension of a sales tax that pays for street maintenance in…
-
The saga over a local memory care center potentially being taken over by its bank…
-
Coan Payton & Payne LLC has promoted Bob Choate and Julie Trent to partners at…
-
Anthony’s Pizza & Pasta is opening a restaurant on Sept. 13 in Fort Collins.
